Imunon, Inc. Files 8-K

Ticker: IMNN · Form: 8-K · Filed: Mar 24, 2025 · CIK: 749647

Sentiment: neutral

Topics: 8-K, corporate-update, filing

Related Tickers: IMNN

TL;DR

Imunon (IMNN) filed an 8-K on 3/24/25. Nothing major, just routine updates.

AI Summary

Imunon, Inc. filed an 8-K on March 24, 2025, reporting other events and financial statements. The company, formerly known as Celsion Corp and Cheung Laboratories Inc, is incorporated in Delaware and headquartered in Lawrenceville, NJ.

Why It Matters

This filing indicates that Imunon, Inc. is providing updates on its corporate activities and financial status to the SEC.

Risk Assessment

Risk Level: low — This is a routine 8-K filing with no specific material events disclosed.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The provided text does not detail the specific 'Other Events' beyond stating that this item is included in the filing.

What is the significance of the former company names listed?

The former company names (Celsion Corp, Cheung Laboratories Inc) indicate historical name changes for Imunon, Inc.

What is the primary business of Imunon, Inc. based on its SIC code?

Imunon, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to 'Pharmaceutical Preparations'.

When was Imunon, Inc. incorporated?

The filing states that Imunon, Inc. is incorporated in Delaware, but the exact date of incorporation is not provided in this excerpt.

What is the address of Imunon, Inc.'s principal executive offices?

The principal executive offices of Imunon, Inc. are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Imunon, Inc. (IMNN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing